GH Research Plc (GHRS)
28.07
+0.71
(+2.60%)
USD |
NASDAQ |
Sep 02, 16:00
28.10
+0.03
(+0.11%)
After-Hours: 20:00
GH Research Research and Development Expense (Annual) : 38.73M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 38.73M |
| December 31, 2024 | 35.00M |
| December 31, 2023 | 29.79M |
| December 31, 2022 | 20.45M |
| Date | Value |
|---|---|
| December 31, 2021 | 8.553M |
| December 31, 2020 | 0.338M |
| December 31, 2019 | 0.296M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Atai Beckley, Inc. | 53.06M |
| Avadel Pharmaceuticals Plc | -- |
| Jazz Pharmaceuticals Plc | 782.74M |
| Eli Lilly & Co. | 13.34B |
| Perrigo Co. Plc | 95.40M |